中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
110-111
,共2页
张爱梅%孟会贤%赵杰%赵莉%冯黎黎
張愛梅%孟會賢%趙傑%趙莉%馮黎黎
장애매%맹회현%조걸%조리%풍려려
米非司酮%子宫内膜异位症%治疗效果
米非司酮%子宮內膜異位癥%治療效果
미비사동%자궁내막이위증%치료효과
Mifepristone%Endometriosis%Treatment effect
目的:探讨米非司酮治疗子宫内膜异位症的临床疗效。方法选择82例子宫内膜异位症并分为两组,观察组采取米非司酮治疗,对照组采取常规治疗。结果观察组治疗总有效率为97.56%,平均子宫内膜厚度为(0.24±0.11)cm;对照组治疗总有效率为68.53%,平均子宫内膜厚度为(0.43±0.39)cm。两组患者比较差异有统计学意义(P<0.05)。结论米非司酮治疗子宫内膜异位症的临床疗效显著。
目的:探討米非司酮治療子宮內膜異位癥的臨床療效。方法選擇82例子宮內膜異位癥併分為兩組,觀察組採取米非司酮治療,對照組採取常規治療。結果觀察組治療總有效率為97.56%,平均子宮內膜厚度為(0.24±0.11)cm;對照組治療總有效率為68.53%,平均子宮內膜厚度為(0.43±0.39)cm。兩組患者比較差異有統計學意義(P<0.05)。結論米非司酮治療子宮內膜異位癥的臨床療效顯著。
목적:탐토미비사동치료자궁내막이위증적림상료효。방법선택82례자궁내막이위증병분위량조,관찰조채취미비사동치료,대조조채취상규치료。결과관찰조치료총유효솔위97.56%,평균자궁내막후도위(0.24±0.11)cm;대조조치료총유효솔위68.53%,평균자궁내막후도위(0.43±0.39)cm。량조환자비교차이유통계학의의(P<0.05)。결론미비사동치료자궁내막이위증적림상료효현저。
Objective To investigate the efficacy of mifepristone in treatment of endometriosis. Methods 82 cases of patients with endometriosis were divided into two groups. The observation group was given mifepristone treatment while the control group was given conventional therapy. Results The total effective rate was 97.56%and the mean endometrial thickness was(0.24±0.11)cm of observation group. In the control group, the total effective rate was 68.53% and the mean endometrial thickness was(0.43±0.39)cm. There was statistical y significant difference between two groups(P<0.05). Conclusion The clinical curative effect of mifepristone in treatment of endometriosis is significant.